go to contents

Akribes Biomedical GmbH

Back to list

Facts

Founded
Staff
5
Organization type
RDM medtech

Profile

Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.

Similar companies in RDM medtech

mySugr GmbH

Organization type
RDM medtech
Cluster
LISAvienna
Details

Otto Bock Healthcare Products GmbH

Organization type
RDM medtech
Region
Vienna
Cluster
LISAvienna
Topic
active implantable devices
assistive products for persons with disability
telemedicine and e-health
software for medicine
Details

VIVISOL HeimbehandlungsgerÀte GmbH

Organization type
RDM medtech
Region
Vienna
Cluster
LISAvienna
Topic
anaesthetic and respiratory devices
Details

Eurolyser Diagnostica GmbH

Organization type
RDM medtech
Region
Salzburg
Cluster
Medical Technology Cluster
Topic
in vitro diagnostic devices
telemedicine and e-health
software for medicine
Details

Contact



Contact: